Abiopharma

Director Li Dean Y 🟢 acquired 88.4K shares of RECURSION PHARMACEUTICALS, INC. (RXRX) Transaction Date: Jun 17, 2026 | Filing ID: 000083

Director Bumpus Namandje 🟡 adjusted position in 84.5K shares of RECURSION PHARMACEUTICALS, INC. (RXRX) at $3.18 Transaction Date: Jun 17, 2026 | Filing ID: 000082

EDGEMOND JAMES 🟡 adjusted position in 10.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $548.90 ($8.3M) Transaction Date: Jun 18, 2026 | Filing ID: 000028

Director McGrann James M. 🟢 acquired 11.3K shares of National Vision Holdings, Inc. (EYE) Transaction Date: Jun 17, 2026 | Filing ID: 000003

Director Connaughton Bernadette 🟢 acquired 51.7K shares (1 derivative) of Editas Medicine, Inc. (EDIT) at $2.55 Transaction Date: Jun 17, 2026 | Filing ID: 000072

RA CAPITAL MANAGEMENT, L.P. 🟢 acquired 34.0K shares (1 derivative) of PepGen Inc. (PEPG) at $1.79 Transaction Date: Jun 18, 2026 | Filing ID: 000684

Director Kelman Naomi 🟢 acquired 11.3K shares of National Vision Holdings, Inc. (EYE) Transaction Date: Jun 17, 2026 | Filing ID: 000003

Gedeon Christelle 🟡 adjusted position in 821.1K shares (1 derivative) of Canopy Growth Corp (CGC) at $0.99 Transaction Date: Jun 17, 2026 | Filing ID: 076410

Director Svindland Paul C. 🟢 acquired 9.5K shares of FORWARD AIR CORP (FWRD) Transaction Date: Jun 18, 2026 | Filing ID: 044652

Director Hopfield Jessica 🟢 acquired 51.7K shares (1 derivative) of Editas Medicine, Inc. (EDIT) at $2.55 Transaction Date: Jun 17, 2026 | Filing ID: 000071